Discover Scientific Knowledge

Showing results for: "lung drug" (31 results)

Organoid-Based Toxicity Testing as a Replacement for Animal Models
Health & Biology

Organoid-Based Toxicity Testing as a Replacement for Animal Models

Animal models have traditionally served as the cornerstone of drug safety evaluation; however, major translational challenges persist due to interspecies differences in physiology, metabolism, and genetic regulation. Many compounds demonstrating favorable toxicity profiles in animals later fail during human trials or are withdrawn post-marketing due to unforeseen adverse effects, especially hepatotoxicity and cardiotoxicity (Lee et al., 2025).

By Jasvitha MandavaNov 9, 2025
Promising Latest Treatment That Could Calm Anxiety for Millions of Americans
Health & Biology

Promising Latest Treatment That Could Calm Anxiety for Millions of Americans

Today, generalized anxiety disorder is affecting millions of Americans. The disorder usually traps the sufferers in cycles of fear and isolation in a way that even standard treatments cannot relieve completely. UCSF neuroscientist Jennifer Mitchell, PhD, is testing a surprising brand-new approach that can ease symptoms of generalized anxiety disorder by reshaping how the brain thinks and feels.

By Electra PadhyNov 21, 2025
Protocols Exposed: Inside Clinical Trial Blueprints
Health & Biology

Protocols Exposed: Inside Clinical Trial Blueprints

This article aims to demystify the anatomy of a clinical trial protocol, peeling back the technical layers to reveal how scientific rigor is converted into medical progress. At ScientistsHub, we often ask: How do we ensure that a medical breakthrough is not just a stroke of luck, but a repeatable, verifiable victory for human health? The answer is found in the design. To truly appreciate the result of any trial, one must first master the architecture of the inquiry.

By Patrick OkoiJan 27, 2026
Unlocking the Fortress: How Nano-Messengers are Rewiring the Future of Brain Medicine
Health & Biology

Unlocking the Fortress: How Nano-Messengers are Rewiring the Future of Brain Medicine

This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.

By Nicolás Mario LisnovskyMar 10, 2026
Page 1 of 2Next →